I am a healthcare professional


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.

Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.

By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.

You can find out more about cookies by browsing our Privacy Policy.


For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

Please select preferred method for the calendar invite

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Welcome to


Roche’s International Medical Congress Platform. Medical congresses bring together healthcare professionals to share information about their specialties. MEDICALLY compiles and shares Roche and Genentech's congress materials from medical congresses around the world.

Medical congresses bring together healthcare professionals to share information about their specialties. MEDICALLY compiles and shares Roche and Genentech's congress materials from medical congresses around the world. Meaning publications related to Roche medicines presented at the main International Scientific Congresses will be made available on this page at the end of the embargo and for a limited period of time.



Medical Information:
The information contained in the materials may include data on experimental drugs and medical devices which are subject to active clinical research , pending approval by any regulatory authority or reimbursement by the RIZIV/INAMI.

This information does not in any way constitute a tool to promote the prescription, supply, sale or consumption of medicines outside of what is stated in the authorized SmPC. It is therefore recommended to use the drug strictly following what is outlined in the SmPC to which reference is made for any further information. For further information on these materials or other medical insights regarding Roche drugs, you can refer to the Medical Department of Roche Belux through the Medical Information number +32 (0)2 525 82 99, the brussels.medinfo@roche.com mailbox or the https://medinfo.roche.com/ portal.

To consult the Summary of Product Characteristics of the individual medicines authorized in Belgium, please refer to the e-compendium website, Roche.be or RochePro websites.

Drug Safety: Concerning Enspryng (satralizumab), Evrysdi (risdiplam), Gavreto (pralsetinib), Lunsumio (mosunetuzumab), Phesgo (pertuzumab & trastuzumab), Polivy (polatuzumab), Ronapreve (casirivimab & imdevimab), Rozlytrek (entrectinib), Vabysmo (faricimab), Xofluza (baloxavir marboxil), Columvi (Glofitamab):

▼ These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the Summary of Product Characteristics (SmPC) for information on how to report adverse reactions.

If a pregnancy occurs while using Herceptin/PERJETA/Kadcyla/Phesgo or within 7 months following the last dose of Herceptin/Kadcyla/Phesgo or within 6 months following the last dose of PERJETA, please immediately report pregnancy to the local Roche Adverse Event line at +32 (0)2 525 82 99.Additional information will be requested during a Herceptin/PERJETA//Phesgo/Kadcyla-exposed pregnancy and the first year of the infant's life. This will enable Roche to better understand the safety of Herceptin/PERJETA/Kadcyla/Phesgo and to provide appropriate information to health authorities, healthcare providers and patients.

The reporting of suspected adverse reactions occurring after the authorization of the medicine is very important, as it allows continuous monitoring of the benefit / risk ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions to Roche Belux as the local MA holder of the drug via the email address brussels.drug_safety@roche.com or via the Roche Belux Adverse Event line at +32 (0)2 525 82 99.

The available publications are documents protected by copyright, i.e. Roche is authorized to distribute a copy of the articles for personal use only, for study or research purposes, and may not be disclosed to third parties. Anyone who reproduces or distributes copies of such publications may be held liable for copyright infringement.


Preview the latest congresses

Browse information about latest congresses and view the congress calendar

No result found

Preview the latest medical materials

Take a look at materials from the latest medical congresses

No result found

Join an ever-growing community

Sign up using LinkedIn or register via email.

Signing up allows you to access exclusive content and personalize your feeds so you see only what’s relevant to you and your practice.